The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOVENTUS INC COM CL A 09075A108 118,884,688 13,021,324 SH SOLE 13,021,324 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 13,983,807 1,084,857 SH SOLE 1,084,857 0 0
MEDICINOVA INC COM NEW 58468P206 1,515,139 1,105,941 SH SOLE 1,105,941 0 0
MIMEDX GROUP INC COM 602496101 111,371,234 28,195,249 SH SOLE 28,195,249 0 0
TELA BIO INC COM 872381108 4,783,120 7,714,709 SH SOLE 7,714,709 0 0